Robotics

COVID-19 threw a gargantuan curveball at medtech, but these industry predictions for 2020 have been surprisingly on point, so far. See what we got right and what we didn't.

Zimmer Biomet revenue across all categories exceeded analyst expectations in the second quarter, despite COVID-19 disruptions, and Rosa placements were also surprisingly strong.

This month marks the 20th anniversary of FDA clearing the da Vinci surgical robotics system for laparoscopic procedures.

The New Brunswick, NJ-based company won’t pursue a 510(k) pathway for the platform and will have first-in-human studies in the late half of 2022.

Telemedicine has emerged as a safe, effective alternative to in-person doctor-patient visits. Can telerobotic surgery follow suit?

A successful partnership between medtech companies and contract manufacturing organizations can help OEMs get products to market faster, meet quality requirements, support Design for Manufacturability, and reduce costs and inventories.

The agency updated its list of frequently-asked questions related to both diagnostic testing and antibody testing for COVID-19.